A2ML1 and hepatocellular carcinoma: After treatment with OSM, the HepG2 cell line exhibited high GP73 expression (a biomarker of HCC), and the serum of patients with HCC and cirrhosis showed higher OMS levels than the control group, indicating a close relationship between OSM and liver diseases [173].